Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms, Plasma Cell × entinostat × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 3 Neoplasm Metastasis 2 Melanoma 2 Carcinoma, Renal Cell 2 Urinary Bladder Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1 Lymphoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Brain Stem Neoplasms 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 28 Dexamethasone 27 Melphalan 21 Busulfan 21 fludarabine phosphate 20 Bortezomib 19 Lenalidomide 18 Tacrolimus 17 Whole-Body Irradiation 15 Peripheral Blood Stem Cell Transplantation 14 Mycophenolic Acid 14 Antilymphocyte Serum 14 fludarabine 12 Calcium Dobesilate 12 Thalidomide 10 Filgrastim 10 Granulocyte Colony-Stimulating Factor 9 Methotrexate 8 pomalidomide 6 Radiotherapy 6 Cyclosporine 6 Stem Cell Transplantation 5 Rituximab 5 Etoposide 5 Cord Blood Stem Cell Transplantation 5 carfilzomib 4 Surveys and Questionnaires 4 Sirolimus 4 Methylprednisolone 4 Hematopoietic Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡